The Negative Outlook reflects the recent operational underperformance against expectations in the current year as Gainwell increased investments in product management and engineering capabilities, along with higher than expected nonrecurring costs related to integration and separation costs. This has resulted in weakened credit protection metrics for the company. Fitch believes that despite short-term pressure on Gainwell's profitability, the investments would strengthen competitive positioning in the Medicaid industry, and margins would become stronger once synergies are achieved.
https://www.fitchratings.com/research/corporate-finance/fitch-revises-gainwell-outlook-to-negative-affirms-idr-at-b-16-03-2023